N-(1-(tert-Butyl)-4-(2-hydroxyphenyl)-1H-pyrazol-3-yl)-2,2,2-trifluoroacetamide

Catalog No. :
ACJAOD256
CAS No. :
1431698-11-1
Molecular Formula :
C15H16F3N3O2
Molecular Weight :
327.31

IUPAC Name:N-(1-(tert-butyl)-4-(2-hydroxyphenyl)-1H-pyrazol-3-yl)-2,2,2-trifluoroacetamide

N-(1-(tert-Butyl)-4-(2-hydroxyphenyl)-1H-pyrazol-3-yl)-2,2,2-trifluoroacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$664.00Login to see priceInquiryInquiry
250mg95%$803.00Login to see priceInquiryInquiry
1g95%$1471.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(1-(tert-Butyl)-4-(2-hydroxyphenyl)-1H-pyrazol-3-yl)-2,2,2-trifluoroacetamide
IUPAC NameN-(1-(tert-butyl)-4-(2-hydroxyphenyl)-1H-pyrazol-3-yl)-2,2,2-trifluoroacetamide
MDL No.MFCD24386282
Molecular FormulaC15H16F3N3O2
Molecular Weight327.31
SMILESO=C(NC1=NN(C(C)(C)C)C=C1C2=CC=CC=C2O)C(F)(F)F
InChI KeyHTADIAGLRHIHFF-UHFFFAOYSA-N
SynonymAcetaMide, N-[1-(1,1-diMethylethyl)-4-(2-hydroxyphenyl)-1H-pyrazol-3-yl]-2,2,2-trifluoro-;N-[1-tert-butyl-4-(2-hydroxyphenyl)pyrazol-3-yl]-2,2,2-trifluoroacetamide
CAS No.1431698-11-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJAOD256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJAOD256 route product structure diagram
    ACJAOD2561431698-11-1
Inquiry

2. ACJAOD256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJAOD256 route product structure diagram
    ACJAOD2561431698-11-1
Inquiry

Comments (0)